On December 24, 2024, [Nicholas Green](https://www.gurufocus.com/insider/64222/nicholas-green), President & CEO of Avid Bioservices Inc (CDMO, Financial), sold 226,653 shares of the company, according to the [SEC Filing](http://www.sec.gov/Archives/edgar/data/704562/000168316824008985/xslF345X01/ownership.xml). Following this transaction, the insider now owns 0 shares of the company.
Avid Bioservices Inc (CDMO) is a contract development and manufacturing organization (CDMO) that provides a comprehensive range of services from process development to commercial manufacturing of biopharmaceutical products derived from mammalian cell culture. The company serves a global client base, including biotechnology and pharmaceutical companies.
The insider transaction history for Avid Bioservices Inc shows that there have been 0 insider buys in total over the past year. Meanwhile, there have been 22 insider sells over the same timeframe.
Over the past year, [Nicholas Green](https://www.gurufocus.com/insider/64222/nicholas-green) has sold a total of 263,245 shares and purchased 0 shares.
Shares of Avid Bioservices Inc were trading for $12.29 apiece on the day of [Nicholas Green](https://www.gurufocus.com/insider/64222/nicholas-green)’s recent sell. This gives the stock a [market cap](https://www.gurufocus.com/term/mktcap/CDMO) of $785.468 million.
With a price of $12.29 and a [GuruFocus Value](https://www.gurufocus.com/term/gf-value/CDMO) of $16.66, Avid Bioservices Inc has a price-to-GF-Value ratio of 0.74. This means the stock is modestly undervalued based on its GF Value.
The [GF Value](https://www.gurufocus.com/term/gf-value/CDMO) is an intrinsic value estimate developed by GuruFocus that is calculated based on the following three factors:
- Historical multiples ([price-earnings ratio](https://www.gurufocus.com/term/pe-ratio/CDMO), [price-sales ratio](https://www.gurufocus.com/term/ps-ratio/CDMO), [price-book ratio](https://www.gurufocus.com/term/pb-ratio/CDMO), and [price-to-free cash flow](https://www.gurufocus.com/term/price-to-free-cash-flow/CDMO)) that the stock has traded at.
- A GuruFocus adjustment factor based on the company’s past returns and growth.
- Future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
